Drug Type siRNA |
Synonyms |
Target |
Action antagonists |
Mechanism CB1 antagonists(Cannabinoid CB1 receptor antagonists), LEPR antagonists(Leptin receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leptin Receptor Deficiency | Preclinical | Canada | 01 Feb 2025 |